A
Ahmedin Jemal
Researcher at American Cancer Society
Publications - 568
Citations - 492750
Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.
Papers
More filters
Journal ArticleDOI
Association of nicotine replacement therapy product sales with menthol cigarette sales restriction in Massachusetts
TL;DR: In this paper, a state-level 4-week aggregate sales of gum, lozenge and patch NRT products converted into pieces per 1000 adults who smoke cigarettes were analyzed.
Journal ArticleDOI
Abstract LB128: Cardiovascular disease mortality among cancer survivors by race and ethnicity in the United States
TL;DR: Nisotel et al. as mentioned in this paper found that cancer survivors have higher cardiovascular disease (CVD) mortality than the general population but comprehensive data by race and ethnicity are limited, thus, targeted primary care and cardio-oncologic intervention strategies are needed to improve CVD outcomes and achieve cardiovascular health equity among cancer survivors.
Journal ArticleDOI
An advocacy-research collaboration model to inform evidence-based tobacco control efforts
Anuja Majmundar,Zheng Xue,Samuel Asare,Catherine MacMahon,Cathy Callaway,Lisa A. Lacasse,Ahmedin Jemal,Nigar Nargis +7 more
TL;DR: In a rapidly evolving tobacco marketplace, research and evidence-based advocacy in action can help avert public health crises and achieve landmark progress in tobacco control as discussed by the authors , which can help aver public health crisis and achieving landmark progress.
Journal ArticleDOI
Axillary lymphatic disruption does not increase risk of breast carcinoma.
Ted Gansler,Ahmedin Jemal +1 more
TL;DR: Clinicians have little evidence (except biological implausibility) to cite in discussing this topic with patients and are unaware of any peer-reviewed research that supports or refutes a causal association between bra use and breast cancer risk, or suggests such an association might be due to reduced lymphatic elimination of toxins.
Journal ArticleDOI
Abstract P1-06-01: Associations of historic and contemporary “redlining” with breast cancer stage at diagnosis
TL;DR: Wiese et al. as discussed by the authors examined the association between the historic HOLC-based "redlining" and contemporary mortgage lending bias and stage of breast cancer at diagnosis among women aged 18 years and older in New Jersey diagnosed with first primary invasive breast cancer in 2010-2015 (N= 32,939).